SNG — Synairgen Income Statement
0.000.00%
Last trade - 00:00
- £13.59m
- -£1.04m
- 16
- 29
- 43
- 18
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.105 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 4.24 | 4.82 | 17.7 | 57.9 | 20.3 |
Operating Profit | -4.13 | -4.82 | -17.7 | -57.9 | -20.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.1 | -4.79 | -17.7 | -57.9 | -20.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.3 | -3.88 | -13.9 | -48.7 | -17.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.3 | -3.88 | -13.9 | -48.7 | -17.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.3 | -3.88 | -13.9 | -48.7 | -17.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.034 | -0.035 | -0.095 | -0.243 | -0.088 |